
### [MONDO:0016633](http://purl.obolibrary.org/obo/MONDO_0016633)
**Label:** rare thrombotic disorder due to a constitutional coagulation factors defect

**Subclasses:** [MONDO:0013144](http://purl.obolibrary.org/obo/MONDO_0013144) (antithrombin III deficiency), [MONDO:0012465](http://purl.obolibrary.org/obo/MONDO_0012465) (hypercoagulability syndrome due to glycosylphosphatidylinositol deficiency), [MONDO:0016320](http://purl.obolibrary.org/obo/MONDO_0016320) (rare hereditary thrombophilia), [MONDO:0012860](http://purl.obolibrary.org/obo/MONDO_0012860) (thrombophilia due to protein c deficiency, autosomal recessive), [MONDO:0013791](http://purl.obolibrary.org/obo/MONDO_0013791) (thrombophilia due to protein S deficiency, autosomal recessive), [MONDO:0018047](http://purl.obolibrary.org/obo/MONDO_0018047) (familial thrombomodulin anomalies), [MONDO:0013143](http://purl.obolibrary.org/obo/MONDO_0013143) (hereditary thrombophilia due to congenital histidine-rich (poly-L) glycoprotein deficiency), [MONDO:0019144](http://purl.obolibrary.org/obo/MONDO_0019144) (hereditary thrombophilia due to congenital protein S deficiency), [MONDO:0019145](http://purl.obolibrary.org/obo/MONDO_0019145) (hereditary thrombophilia due to congenital protein c deficiency), [MONDO:0009315](http://purl.obolibrary.org/obo/MONDO_0009315) (factor XII deficiency), [MONDO:0008316](http://purl.obolibrary.org/obo/MONDO_0008316) (thrombophilia due to protein c deficiency, autosomal dominant), [MONDO:0012868](http://purl.obolibrary.org/obo/MONDO_0012868) (protein S acquired deficiency), 

**Corr. equiv. classes:** [Orphanet:330](http://www.orpha.net/ORDO/Orphanet_330), [Orphanet:83639](http://www.orpha.net/ORDO/Orphanet_83639), [Orphanet:217467](http://www.orpha.net/ORDO/Orphanet_217467), [OMIM:610293](http://purl.obolibrary.org/obo/OMIM_610293), [OMIM:176860](http://purl.obolibrary.org/obo/OMIM_176860), [OMIM:614514](http://purl.obolibrary.org/obo/OMIM_614514), [Orphanet:217454](http://www.orpha.net/ORDO/Orphanet_217454), [OMIM:612336](http://purl.obolibrary.org/obo/OMIM_612336), [OMIM:613116](http://purl.obolibrary.org/obo/OMIM_613116), [Orphanet:26349](http://www.orpha.net/ORDO/Orphanet_26349), [OMIM:612304](http://purl.obolibrary.org/obo/OMIM_612304), [OMIM:613118](http://purl.obolibrary.org/obo/OMIM_613118), [Orphanet:745](http://www.orpha.net/ORDO/Orphanet_745), [Orphanet:82](http://www.orpha.net/ORDO/Orphanet_82), [OMIM:234000](http://purl.obolibrary.org/obo/OMIM_234000), [Orphanet:3324](http://www.orpha.net/ORDO/Orphanet_3324), [Orphanet:743](http://www.orpha.net/ORDO/Orphanet_743), 

**Class expressions from DL-Learner:**

- [HP:0004418](http://purl.obolibrary.org/obo/HP_0004418) (Thrombophlebitis) and [HP:0030875](http://purl.obolibrary.org/obo/HP_0030875) (Abnormality of pulmonary circulation) 54.23%
- [HP:0002204](http://purl.obolibrary.org/obo/HP_0002204) (Pulmonary embolism) and [HP:0004418](http://purl.obolibrary.org/obo/HP_0004418) (Thrombophlebitis) 54.23%
- [HP:0004418](http://purl.obolibrary.org/obo/HP_0004418) (Thrombophlebitis) and (not ([HP:0011842](http://purl.obolibrary.org/obo/HP_0011842) (Abnormality of skeletal morphology))) 54.23%
- [HP:0004418](http://purl.obolibrary.org/obo/HP_0004418) (Thrombophlebitis) and (not ([HP:0010978](http://purl.obolibrary.org/obo/HP_0010978) (Abnormality of immune system physiology))) 54.23%
- [HP:0004418](http://purl.obolibrary.org/obo/HP_0004418) (Thrombophlebitis) and (not ([HP:0004419](http://purl.obolibrary.org/obo/HP_0004419) (Recurrent thrombophlebitis))) 54.23%
- [HP:0004418](http://purl.obolibrary.org/obo/HP_0004418) (Thrombophlebitis) and (not ([HP:0002715](http://purl.obolibrary.org/obo/HP_0002715) (Abnormality of the immune system))) 54.23%
- [HP:0004418](http://purl.obolibrary.org/obo/HP_0004418) (Thrombophlebitis) and (not ([HP:0000924](http://purl.obolibrary.org/obo/HP_0000924) (Abnormality of the skeletal system))) 54.23%
- [HP:0004418](http://purl.obolibrary.org/obo/HP_0004418) (Thrombophlebitis) and (not ([HP:0000119](http://purl.obolibrary.org/obo/HP_0000119) (Abnormality of the genitourinary system))) 54.23%
- [HP:0002795](http://purl.obolibrary.org/obo/HP_0002795) (Functional respiratory abnormality) and [HP:0004418](http://purl.obolibrary.org/obo/HP_0004418) (Thrombophlebitis) and [HP:0030163](http://purl.obolibrary.org/obo/HP_0030163) (Abnormal vascular physiology) 54.23%
- [HP:0002795](http://purl.obolibrary.org/obo/HP_0002795) (Functional respiratory abnormality) and [HP:0004418](http://purl.obolibrary.org/obo/HP_0004418) (Thrombophlebitis) and [HP:0011025](http://purl.obolibrary.org/obo/HP_0011025) (Abnormality of cardiovascular system physiology) 54.23%
- [HP:0002086](http://purl.obolibrary.org/obo/HP_0002086) (Abnormality of the respiratory system) and [HP:0004418](http://purl.obolibrary.org/obo/HP_0004418) (Thrombophlebitis) and [HP:0030163](http://purl.obolibrary.org/obo/HP_0030163) (Abnormal vascular physiology) 54.23%
- [HP:0002086](http://purl.obolibrary.org/obo/HP_0002086) (Abnormality of the respiratory system) and [HP:0004418](http://purl.obolibrary.org/obo/HP_0004418) (Thrombophlebitis) and [HP:0011025](http://purl.obolibrary.org/obo/HP_0011025) (Abnormality of cardiovascular system physiology) 54.23%
- [HP:0004418](http://purl.obolibrary.org/obo/HP_0004418) (Thrombophlebitis) and [HP:0030163](http://purl.obolibrary.org/obo/HP_0030163) (Abnormal vascular physiology) 51.97%
- [HP:0004418](http://purl.obolibrary.org/obo/HP_0004418) (Thrombophlebitis) and [HP:0011025](http://purl.obolibrary.org/obo/HP_0011025) (Abnormality of cardiovascular system physiology) 51.97%
- [HP:0002795](http://purl.obolibrary.org/obo/HP_0002795) (Functional respiratory abnormality) and [HP:0004418](http://purl.obolibrary.org/obo/HP_0004418) (Thrombophlebitis) 51.97%


